Literature DB >> 23571413

Management of pregnancies with confirmed cytomegalovirus fetal infection.

Guillaume Benoist1, Marianne Leruez-Ville, Jean François Magny, François Jacquemard, Laurent J Salomon, Yves Ville.   

Abstract

Systematic screening for cytomegalovirus (CMV) maternal infection is not recommended in most countries. Nevertheless, primary CMV infection will occur in around 1% of women. The vertical transmission rate is estimated to be around 30-50%. Newborns with congenital CMV infection remain asymptomatic in the majority of cases and around 10% will present with a wide range of abnormalities. Fetal infection can be diagnosed by amniocentesis with amplification of the viral genome in the amniotic fluid by polymerase chain reaction. This prenatal diagnosis is mainly performed when ultrasound abnormalities are observed. The purpose of this mini-review is to describe the management options when a fetus is known to be infected.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23571413     DOI: 10.1159/000342752

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  19 in total

1.  Human cytomegalovirus infection interferes with the maintenance and differentiation of trophoblast progenitor cells of the human placenta.

Authors:  Takako Tabata; Matthew Petitt; Martin Zydek; June Fang-Hoover; Nicholas Larocque; Mitsuru Tsuge; Matthew Gormley; Lawrence M Kauvar; Lenore Pereira
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

2.  Incidence of CMV co-infection in HIV-positive women and their neonates in a tertiary referral centre: a cohort study.

Authors:  A Reitter; H Buxmann; A E Haberl; R Schlösser; M Kreibich; O T Keppler; A Berger
Journal:  Med Microbiol Immunol       Date:  2015-07-09       Impact factor: 3.402

3.  Results of life-supporting galactosyltransferase knockout kidneys in cynomolgus monkeys using two different sources of galactosyltransferase knockout Swine.

Authors:  Mitsuhiro Sekijima; Shiori Waki; Hisashi Sahara; Masayuki Tasaki; Robert A Wilkinson; Vincenzo Villani; Yoshiki Shimatsu; Kazuaki Nakano; Hitomi Matsunari; Hiroshi Nagashima; Jay A Fishman; Akira Shimizu; Kazuhiko Yamada
Journal:  Transplantation       Date:  2014-08-27       Impact factor: 4.939

Review 4.  Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes.

Authors:  Alice Panchaud; Miloš Stojanov; Anne Ammerdorffer; Manon Vouga; David Baud
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

Review 5.  [A review on the prevention and treatment of congenital cytomegalovirus infection in mothers and infants].

Authors:  Wen-Fang Xu; Tian-Ming Yuan
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-10

6.  Impact of socioeconomic risk factors on the seroprevalence of cytomegalovirus infections in a cohort of pregnant Polish women between 2010 and 2011.

Authors:  W Wujcicka; Z Gaj; J Wilczyński; W Sobala; E Spiewak; D Nowakowska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-06       Impact factor: 3.267

7.  HCMV infection of human trophoblast progenitor cells of the placenta is neutralized by a human monoclonal antibody to glycoprotein B and not by antibodies to the pentamer complex.

Authors:  Martin Zydek; Matthew Petitt; June Fang-Hoover; Barbara Adler; Lawrence M Kauvar; Lenore Pereira; Takako Tabata
Journal:  Viruses       Date:  2014-03-19       Impact factor: 5.048

8.  TLR9 2848 GA heterozygotic status possibly predisposes fetuses and newborns to congenital infection with human cytomegalovirus.

Authors:  Wioletta Wujcicka; Edyta Paradowska; Mirosława Studzińska; Zuzanna Gaj; Jan Wilczyński; Zbigniew Leśnikowski; Dorota Nowakowska
Journal:  PLoS One       Date:  2015-04-06       Impact factor: 3.240

9.  Crystal Structure of the Human Cytomegalovirus Glycoprotein B.

Authors:  Heidi G Burke; Ekaterina E Heldwein
Journal:  PLoS Pathog       Date:  2015-10-20       Impact factor: 6.823

10.  Identification of Symptomatic Fetuses Infected with Cytomegalovirus Using Amniotic Fluid Peptide Biomarkers.

Authors:  Cyrille Desveaux; Julie Klein; Marianne Leruez-Ville; Adela Ramirez-Torres; Chrystelle Lacroix; Benjamin Breuil; Carine Froment; Jean-Loup Bascands; Joost P Schanstra; Yves Ville
Journal:  PLoS Pathog       Date:  2016-01-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.